Cabot Corp.

Cabot Corp. has achieved a new 52-week high, reflecting a recovery from its previous low. Despite a challenging year, the company maintains a market capitalization of USD 3,594 million, a competitive P/E ratio, and strong financial metrics, indicating resilience in the specialty chemicals industry.

Cabot Corp., a small-cap specialty chemicals company, has recently adjusted its valuation, showcasing a favorable P/E ratio of 10 and an EV to EBITDA of 5.91. With strong profitability metrics, including a ROCE of 24.36% and ROE of 22.53%, it presents a stable financial outlook compared to peers.

Cabot Corp., a small-cap specialty chemicals company, has adjusted its valuation, now featuring a P/E ratio of 10 and an enterprise value to EBITDA of 5.91. With strong profitability metrics, including a ROCE of 24.36% and a ROE of 22.53%, Cabot presents an appealing profile compared to industry peers.

Cabot Corp., a small-cap specialty chemicals company, has adjusted its valuation, with its stock price at $75.29. Over the past year, it has seen a -10.37% return, while year-to-date performance shows a 13.59% gain. Key metrics include a P/E ratio of 10 and a strong ROCE of 24.36%.

Cabot Corp., a small-cap specialty chemicals company, has a P/E ratio of 10, lower than some peers, and reports a price-to-book value of 2.28. With a strong ROCE of 24.36% and ROE of 22.53%, it offers a 2.72% dividend yield, though it has faced a performance decline over the past year.

Cabot Corp., a small-cap specialty chemicals company, has seen its stock price rise slightly to $74.11. The company has experienced significant volatility over the past year, with a high of $84.44 and a low of $58.33. Recent performance shows resilience, outperforming the S&P 500 in the short term, though longer-term returns have lagged behind the broader market.

Cabot Corp., a small-cap specialty chemicals company, has adjusted its valuation, currently priced at $67.82. Over the past year, it has seen a return of -19.66%. Key metrics include a P/E ratio of 10 and a strong ROCE of 24.36%, highlighting its competitive position in the industry.

Cabot Corp., a small-cap specialty chemicals company, has faced a notable decline of 17.61% over the past year, contrasting with the S&P 500's gains. Technical indicators present a mixed outlook, reflecting volatility and competitive pressures in the sector, necessitating close attention to market dynamics.

Cabot Corp., a small-cap specialty chemicals company, has recently experienced a Golden Cross, indicating a potential shift in momentum. While daily indicators show mild bullishness, longer-term metrics present mixed signals. The stock has faced challenges over the past year but has shown resilience with positive year-to-date performance.

Cabot Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. Despite this, the company maintains a solid market capitalization and favorable financial metrics, including a strong return on equity and healthy cash flow, while managing raw material costs effectively.

Cabot Corp., a small-cap specialty chemicals company, recently hit a 52-week low, reflecting a significant decline over the past year. Despite this, it maintains a market cap of USD 4,326 million, a P/E ratio of 9.00, and a solid dividend yield, alongside positive operational metrics.

Cabot Corp., a small-cap specialty chemicals company, has reached a 52-week low, with a significant decline in stock performance over the past year. Despite this, it maintains a market capitalization of USD 4,326 million, a solid return on equity, and reported strong operating cash flow.

Cabot Corp., a small-cap specialty chemicals company, has adjusted its valuation, showcasing a favorable price-to-earnings ratio of 9. With strong profitability metrics, including a return on capital employed of 25.57% and a return on equity of 32.92%, it presents an attractive profile compared to industry peers.

Cabot Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. Despite this, the company maintains a solid market capitalization, attractive valuation metrics, and strong financial health, including a healthy debt-to-equity ratio and robust operating cash flow.

Cabot Corp., a small-cap specialty chemicals company, has hit a new 52-week low, reflecting a notable decline in stock performance over the past year. Despite this, the firm maintains a solid market capitalization, attractive valuation metrics, and positive operating cash flow, while also drawing interest from institutional investors.

Cabot Corp., a small-cap specialty chemicals company, has seen its stock price decline recently, reflecting a bearish sentiment in technical indicators. Over the past year, the stock has underperformed compared to the S&P 500, with significant declines year-to-date, despite positive returns over longer periods.